Eledon Pharmaceuticals (ELDN) Goodwill & Intangibles (2017 - 2022)

Eledon Pharmaceuticals (ELDN) has 6 years of Goodwill & Intangibles data on file, last reported at $48.6 million in Q3 2022.

• Quarterly Goodwill & Intangibles changed 0.0% year-over-year to $48.6 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $48.6 million (changed 0.0% YoY) and the FY2021 annual result came in at $48.6 million, changed 0.0% from the prior year.
• Goodwill & Intangibles held at $48.6 million in Q3 2022, from $48.6 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $48.6 million in Q4 2020 to a low of $1.9 million in Q1 2018.
• A 5-year average of $27.9 million and a median of $46.6 million in 2020 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2018 — Goodwill & Intangibles changed 0.0% — and 2020, when it jumped 2281.68%.
• Tracing ELDN's Goodwill & Intangibles over 5 years: stood at $1.9 million in 2018, then changed by 0.0% to $1.9 million in 2019, then surged by 2505.68% to $48.6 million in 2020, then changed by 0.0% to $48.6 million in 2021, then changed by 0.0% to $48.6 million in 2022.
• The last three Goodwill & Intangibles figures came in at $48.6 million (Q3 2022), $48.6 million (Q2 2022), and $48.6 million (Q1 2022), per Business Quant data.